Page 1 of Clinical Trials for Emetogenic, 135 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
A Multicenter, Open-Label, Single-Arm Evaluation of Palonosetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Who Have Experienced CINV(Chemotherapy-Induced Nausea and Vomiting) During the Previous Cycle of Low Emetogenic Chemotherapy (LEC)
Last Updated: January 5, 2011
Condition(s): Patients With Confirmed Malignant Disease to Receive Low Emetogenic Chemotherapy (LEC) or Who Experienced at Least Nausea and Vomiting During Last Cycle of LEC
2
Completed
CV Events in Emetogenic Chemotherapy
Last Updated: June 2, 2011
Condition(s): Vomiting; Cardiovascular Event; Arterial Thromboembolic Event
3
Completed
Study With Palonosetron Alone in Preventing Chemotherapy-induced Nausea and Vomiting in Untreated Patients With Aggressive Non Hodgkin's Lymphomas Who Underwent Moderately Emetogenic Chemotherapy
Last Updated: November 24, 2009
Condition(s): Chemotherapy-Induced Nausea and Vomiting; Non Hodgkin's Lymphoma
4
Recruiting
Rescue Emetic Therapy for Children Having Elective Surgery
Last Updated: June 21, 2011
Condition(s): Post Operative Nausea and Vomiting; Rescue Emetic Therapy
5
Completed
Palonosetron in Moderately and Highly Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04935)(COMPLETED)
Last Updated: May 23, 2008
Condition(s): Neoplasms; Nausea; Vomiting
6
Completed
Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594)(COMPLETED)
Last Updated: September 30, 2009
Condition(s): Neoplasms; Nausea; Vomiting
7
Completed
Comparative Study of Palonosetron With Granisetron as a Control in Patients Receiving Highly Emetogenic Chemotherapy
Last Updated: July 6, 2011
Condition(s): Chemotherapy-Induced Nausea and Vomiting
8
Completed
Phase 2 Study of Efficacy, Tolerability, and Safety of Intranasal Granisetron for Chemo-Induced Nausea and Vomiting
Last Updated: July 5, 2011
Condition(s): Chemotherapy-Induced Nausea and Vomiting
9
Withdrawn
A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic Chemotherapy
Last Updated: July 30, 2009
Condition(s): Cancer; Chemotherapy-Induced Nausea and Vomiting; Nausea and Vomiting; Solid Tumor Cancer
10
Not yet recruiting
Aprepitant for Prevention of Acute and Delayed Nausea and Vomiting in Patients Receiving a High-emetogenic Dose of Cyclophosphamide for Peripheral Blood Stem Cells Harvesting
Last Updated: March 16, 2010
Condition(s): Nausea; Vomiting
11
Not yet recruiting
A Study to Evaluate the Anti-emetic Effect of Aprepitant Versus Placebo as an Add-on Therapy in Children and Adolescent Receiving Chemotherapy
Last Updated: July 25, 2011
Condition(s): Chemotherapy Induced Nausea and Vomiting
12
Completed
A Study of the Drug Casopitant for the Prevention of Nausea Caused By Cisplatin-Based Highly Emetogenic Chemotherapy
Last Updated: October 13, 2010
Condition(s): Nausea; Vomiting
13
Completed
Emend for Multiple-day Emetogenic Chemotherapy
Last Updated: August 6, 2009
Condition(s): Nausea; Vomiting
14
Recruiting
A Safety and Efficacy Study of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Highly Emetogenic Chemotherapy
Last Updated: May 14, 2012
Condition(s): Chemotherapy-induced Nausea and Vomiting
15
Recruiting
A Safety and Efficacy Study of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Moderately Emetogenic Chemotherapy
Last Updated: May 14, 2012
Condition(s): Chemotherapy-induced Nausea and Vomiting
16
Recruiting
Phase 3 Safety and Efficacy Study of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Highly Emetogenic Chemotherapy
Last Updated: May 14, 2012
Condition(s): Chemotherapy-induced Nausea and Vomiting
17
Completed
Epidemiological EMESIS-Registry
Last Updated: February 8, 2010
Condition(s): Antiemetic Therapy
18
Completed
Comparison of Aprepitant Versus Gabapentin in the Prevention of Delayed Nausea and Vomiting
Last Updated: September 23, 2011
Condition(s): Cancer
19
Completed
Dexamethasone Study: Impact on Quality of Life of Continuing Dexamethasone Following Emetogenic Chemotherapy
Last Updated: March 18, 2011
Condition(s): Cancer; Emesis; Nausea
20
Suspended
Comparison of Delta-8-THC to Ondansetron in the Prevention of Acute Nausea From Moderately Emetogenic Chemotherapy
Last Updated: February 27, 2007
Condition(s): Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Emetogenic

Page 1 of Clinical Trials for Emetogenic, 135 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About